Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,147.42. The company's market cap stands at 1.11T, with a P/E ratio of 43.56 and a dividend yield of 0.53%.
During the trading session on 2026-07-31, Eli Lilly(LLY) shares reached a daily high of $1,159.00 and a low of $1,119.00. At a current price of $1,147.42, the stock is +2.5% higher than the low and still -1.0% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 1.8M, versus its average volume of 2.21M.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
LLY News
Key Points Both companies are giants in diabetes and obesity treatments. Lately, Eli Lilly has moved ahead in the obesity segment. Things could change, howev...
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Eli Lilly didn't make the cut. Grab the names FREE today . Novo pre-announ...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...
Analyst ratings
81%
of 31 ratingsMore LLY News
Eli Lilly’s (LLY) stock is down 4% on July 30 after the pharmaceutical giant announced plans to invest another $750 million to expand its U.S. manufacturing cap...
Key Points Revolution Medicines has a promising cancer drug in development. Even with this medicine's prospects, the stock's valuation looks too frothy. 10 s...
Key Points Amgen wants a slice of the weight loss drug market. Its candidate for capturing that market share might not be up to the task. Its competitors are...
Key Points Eli Lilly currently displays stronger upward momentum in top-line growth, whereas Johnson & Johnson maintains a higher but flatter overall baseline....
Key Points One of Cathie Wood's funds just sold some AtaiBeckley shares. It also bought some Compass Pathways shares. This move makes total sense given that...
GH Research stock has surged 111.2% year to date, yet its valuation checks indicate the shares do not screen as a clear bargain. Investors are weighing that str...
Key Points Eli Lilly's newest acquisition will expand its neuroscience portfolio. The company is bracing for stiff competition within its core therapeutic are...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.